Skip to content
Research Article Open access CC BY 4.0

Serological Changes of Monoclonal Antibody CAMA3C8 against Human Breast Cancer Cell Line

N. Muninathan, K. Ponnazhagan, T. S. Meghalatha

Journal of Pharmaceutical Research International · pp. 406–412 · Published 16 Dec 2021

10.9734/jpri/2021/v33i59A34284

Abstract

Background: Tumor associated antigen are glycoproteins and glycolipids expressed on the surface or in the cytoplasm of tumor cells. The antigenic components are shed from the tumor cells into the tissue culture medium or blood or other human body fluids like human milk. Objective: In the present study, investigate the serological assay of the antigen recognized by CAMA3C8 in patients with carcinoma of the breast. Methods: The study is desgriptive cross section study.The study was divited into four groups based on the expression of tumor associated antigen. Results: In breast cancer CAMA3C8 levels were significantly increased in stage 4 when compared with stage 1 breast cancer cell line.  Conclusion: In the present study, we conclude that significantly recognized CAMA3C8 defined antigens in breast cancer.

Monoclonal antibody breast cancer tumor associated antigen serological techniques

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

7

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.